Interstitial lung changes and persistent COVID ‐19 in a patient with follicular lymphoma: A case report
Herein, we report a case of COVID-19 persisting longer than 11 months which developed interstitial changes in the lungs that were recalcitrant to corticosteroid therapy. AbstractWe herein report a case of interstitial lung changes in a patient with prolonged coronavirus disease 2019 (COVID-19) with follicular lymphoma receiving rituximab and bendamustine who recovered after treatment with a combination therapy consisting of corticosteroids and immunosuppressive agents. There is currently no treatment strategy for prolonged pneumonitis following COVID-19, which can be life-threatening for immunocompromised patients. Thus, further investigation is warranted.
Source: Respirology Case Reports - Category: Respiratory Medicine Authors: Makiko Yomota,
Masaru Tanaka,
Takayuki Kobayashi,
Masatake Kitano,
Saori Ikeda,
Yusuke Kanemasa,
Noriyo Yanagawa,
Yukio Hosomi Tags: CASE REPORT Source Type: research
More News: Coronavirus | Corticosteroid Therapy | COVID-19 | Lymphoma | Respiratory Medicine | Rituxan | Treanda